Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post–Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study)
Titel:
Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post–Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study)
Auteur:
Pina, Liza Miriam Dong, Xiangwen Zhang, Liping Samtani, Mahesh N. Michelson, Alan D. Justino, Henri Bonnet, Damien Harris, Kevin C. Jefferies, John McCrindle, Brian W. Li, Jennifer S.